Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Complementary and Alternative Medical Lab Testing Part 10: Obstetrics
    Complementary and Alternative Medical Lab Testing Part 10: Obstetrics
    Complementary and Alternative Medical Lab Testing Part 10: Obstetrics
    Ebook159 pages2 hours

    Complementary and Alternative Medical Lab Testing Part 10: Obstetrics

    By Ronald Steriti

    ()

    Read preview

    About this ebook

    Complementary and Alternative Medical Lab Testing (CAM Labs) contains summaries of the published research on lab tests, primarily from PubMed trials on humans. Each chapter (disease) begins with a brief summary of conventional lab tests, followed by additional lab tests, including diabetes, insulin resistance, metabolic syndrome, inflammation, etc. There are sections on endocrine hormones (thyroid, adrenal, sex steroids) and environmental medicine (toxic heavy metals). The nutritional assessments section includes minerals, vitamins and amino acids.

    CAM Labs 10 – Obstetrics

    1. Gestational Diabetes
    2. Miscarriage
    3. Nausea And Vomiting Of Pregnancy
    4. Postpartum Depression
    5. Preeclampsia
    6. Pregnancy-Associated Hypertension
    7. Pregnancy (Prenatal)
    8. Recurrent Pregnancy Loss

    LanguageEnglish
    PublisherRonald Steriti
    Release dateJun 4, 2016
    ISBN9781311325730
    Complementary and Alternative Medical Lab Testing Part 10: Obstetrics
    Author

    Ronald Steriti

    Dr. Ronald Steriti is a graduate of Southwest College of Naturopathic Medicine and currently is researcher for Jonathan V. Wright at the Tahoma Clinic.

    Read more from Ronald Steriti

    Related to Complementary and Alternative Medical Lab Testing Part 10

    Related ebooks

    Wellness For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Drug Makes Weight Loss Easier For People With Genetic Obesity

      Jun 3, 2018

      An already-available medication may help people with a certain type of genetically caused obesity lose weight and keep it off. Around two to six percent of all people with obesity develop it in early childhood; it’s in their genetic cards. Mutations

      2 min read

    • Article

      Overweight Women Can Safely Restrict Weight Gain During Pregnancy

      Sep 25, 2018

      Being obese or overweight while pregnant can pose serious health risks for both mother and baby. Now, researchers say that with proper nutrition guidance, restricting weight gain during pregnancy is both safe and feasible. In a new study, women who w

      4 min read

    • Article

      Thyroid Hormone Shows Promise For Fighting Liver Disease

      Sep 13, 2018

      A thyroid hormone shows promise in fighting non-alcoholic fatty liver disease in patients with diabetes, according to new research. The disease, a major global health problem characterized by accumulation of fat in the liver, develops in patients wit

      2 min read

    • Article

      YOUR Healthy Life

      Oct 22, 2020

      YOUR Healthy Life
      6 min read

    • Article

      This Diet May Make Cancer Drugs More Effective

      Jul 5, 2018

      A very low-carbohydrate, high-fat diet called the ketogenic diet may improve the effectiveness of an emerging class of cancer drugs, according to new research. In a study in Nature, scientists provide a possible explanation for why the drugs, which t

      3 min read

    • Article

      Top health

      Oct 27, 2023

      Top health
      2 min read

    • Article

      Prevalence of Depressive and Anxiety Symptoms in Adults with Type 2 Diabetes, Peshawar, KPK, Pakistan

      Mar 1, 2022

      1 3rd Year Medical Student, Mohammed Bin Rashid University, MBRU, Dubai, UAE 2 Family Medicine, Medcare Medical Centre Jumeirah, Dubai, UAE 3 Nutritionist and Consultant Endocrinology, AIMS Sugar Hospital, Hayatabad, Peshawar, Pakistan 4 School of Pu

      18 min read

    • Article

      Pregnant Question

      Sep 11, 2022

      Pregnant Question
      3 min read

    • Article

      Fight Fat Fight Cancer

      Dec 29, 2019

      Fight Fat Fight Cancer
      11 min read

    • Article

      What You Eat & Your Genes

      Sep 2, 2021

      What You Eat & Your Genes
      5 min read

    • Article

      YOUR Healthy Life

      Dec 15, 2021

      YOUR Healthy Life
      4 min read

    • Article

      KETO vs PALEO What Does the Science Say?

      May 31, 2018

      There will always be some type of low carb diet that gets the wellness community excited and most of these diets focus on decreasing the intake of sugar and carbohydrates. Today, the two most popular low carb diets are the ketogenic diet and the pale

      4 min read

    • Article

      Health Now

      Apr 8, 2020

      Researchers have likened brunch to the equivalent of jet-lag, saying the digression from a regular eating schedule can be as disruptive as the body confusion of changing from one time zone to another. In particular, our Sunday brunch could be linked

      8 min read

    • Article

      Fasting And Your hormones

      Nov 20, 2022

      We’re all aware that hormones play a critical role in everything from the quality of our sleep to our mood. Women in particular see this impact played out in our lives every single month. And, given that fasting has such a profound effect on our bodi

      4 min read

    • Article

      Metabolic Syndrome Starts Sooner If You Have PCOS

      Dec 19, 2018

      Women with polycystic ovary syndrome develop metabolic syndrome earlier than women without the condition—which likely puts them at higher risk of developing diabetes and cardiovascular disease, according to a new study. Unlike other studies that exam

      2 min read

    • Article

      Can You Manage PCOS WITH FOOD?

      May 5, 2021

      Can You Manage PCOS WITH FOOD?
      2 min read

    • Article

      A Bigger Breakfast Might Be Better

      Aug 7, 2020

      Is breakfast the most important meal of the day? It’s a topic that’s been debated for a century or more. The issue of breakfast is of special interest to people with diabetes because some research suggests that whether or not a person eats breakfast

      2 min read

    • Article

      BREAST CANCER: Can We Prevent It?

      Sep 22, 2017

      Breast cancer is a leading cause of death in women aged 45-55, but nowadays it’s affecting women in their late 20s too. The majority of these cases are hormonesensitive breast cancers. The breast-cancer risk factors supported by research and conventi

      3 min read

    • Article

      YOUR Healthy Life

      Feb 13, 2020

      Today, many children and young adults are sporting an insulin pump, which automatically measures your BGLs, transmitting details to a smartphone or portable reader. As this technology takes readings of BGLs at all hours of the day for up to two weeks

      6 min read

    • Article

      Weight Management

      Oct 9, 2020

      Weight Management
      2 min read

    • Article

      Comment On Menopause Test

      Sep 1, 2019

      The Menopause Test measures oestradiol, progesterone, FSH, LH, FSH to LH ratio, testosterone, free testosterone, and SHBG which are the key hormones. When you receive your results, they are scored as low, in the middle range, or high. Whilst my oestr

      2 min read

    Related categories

    Reviews for Complementary and Alternative Medical Lab Testing Part 10

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words

      Book preview

      Complementary and Alternative Medical Lab Testing Part 10 - Ronald Steriti

      Complementary and Alternative

      Medical Lab Testing

      Part 10: Obstetrics

      By Ronald Steriti, ND, PhD

      ©

      Complementary and Alternative Medical Lab Testing Clinician’s Guide Part 10: Obstetrics

      By Ronald Steriti, ND, PhD

      Copyright © 2016

      All rights reserved. No part of this book may be reproduced in any form or by any means, including photocopying, including in a web site, or stored in a retrieval system, or transmitted in any form by any means, without expressed, written permission of the copyright owner.

      The contents of this document are the sole property of the author.

      Disclaimer

      This book has not been evaluated by the FDA and is not intended to diagnose, treat, cure or prevent any disease.

      The information contained in this book is for educational purposes only, and should not be construed as medical advice or instruction. No action should be taken based solely on the contents of this book. Readers should consult appropriate health officials.

      While extensive efforts have been made to ensure the accuracy of the information contained, the possibility of errors, omissions, and misinterpretations cannot be ruled out. The reader is advised to consult the original references for verification and clarification.

      Foreward

      This book is a summary the published research on lab tests, primarily from PubMed. The studies are limited to those with trials on humans. As such, some labs may be excluded due to the lack of published research. That is simply a reflection of the current state of research - much more work is needed!

      Although this book may be useful for differential diagnosis, lab tests are can also be used to identify inderlying causes and associated conditions.

      The sections on conventional lab tests are purposefully brief. These tests are typically used to confirm a diagnosis. There are other more comprehensive sources of information on conventional medical lab testing.

      Table of Contents

      1. Gestational Diabetes

      2. Miscarriage

      3. Nausea And Vomiting Of Pregnancy

      4. Postpartum Depression

      5. Preeclampsia

      6. Pregnancy-Associated Hypertension

      7. Pregnancy (Prenatal)

      8. Recurrent Pregnancy Loss

      Chapter 1. Gestational Diabetes

      Conventional Lab Tests

      50-g, 1-hour glucose challenge test (GCT)

      100-g, 3-hour oral glucose tolerance test (OGTT) (if GCT is abnormal)

      Fasting glucose, hemoglobin A1C

      BUN and creatinine

      TSH and Free thyroxine

      Spot urine protein-to-creatinine ratio

      Additional Lab Tests

      Insulin Resistance, Metabolic Syndrome

      1254 Polish Caucasian women with GDM were recruited into the study. The HOMA-IR in the whole population ranged from 0.34 to 20.39. BMI, fasting insulin, fasting glucose and insulin dose per day increased along with increasing quartiles (HOMA-IR > 1.29). We observed a decrease of HOMA-B in the third quartile(1.92-2.89) compared with the first quartile(0.34-1.29). Insulin treatment was associated with HOMA-IR(<1.29 vs. >2.89), OR: 3.37, fasting glucose(<=6.11 vs. >6.11 mmol/dl), OR: 2.61, age (<=30 vs. >30 y. o.), OR: 1.54, and BMI(<25 vs. >=25 kg/m2), OR: 1.45. Maximum insulin dose was associated with HOMA-IR, OR: 2.00, after adjustment for family history of diabetes, and 2-h OGTT glucose. Insulin resistance assessed by the HOMA index at diagnosis is associated with the severity and pathophysiological heterogeneity of GDM. A HOMA-IR >1.29 points to the major role of insulin resistance, indicating the need for a treatment aimed at improving tissue sensitivity to insulin. A HOMA-IR 1.29-2.89 suggests reduced insulin secretion, which is an indication for the introduction of insulin therapy. A HOMA-IR >2.89 indicates insufficient compensation for insulin resistance, which suggests the need for a treatment aimed at improving susceptibility of tissues to insulin combined with insulin therapy. (Sokup et al., 2013)

      A cross-sectional study was performed with 1,163 pregnant women with positive (1-hour plasma glucose >/= 7.2 mmol/L) in a 50-g oral glucose challenge test (OGCT). The 100-g oral glucose tolerance test (OGTT) was used to stratify the participants into three groups: NGT (n = 588), GIGT (n = 294), and GDM (n = 281). The GDM group had higher homeostasis model assessment of insulin resistance and lower insulin sensitivity index (ISOGTT), quantitative insulin sensitivity check index, homeostasis model assessment for estimation of index beta-cell secretion (HOMA-B), first and second phase insulin secretion, and insulin secretion-sensitivity index (ISSI) than the NGT group (p

      C-Reactive Protein (CRP)

      In a cohort of Hispanic women with recent gestational diabetes mellitus, oral glucose tolerance tests (OGTTs), intravenous glucose tolerance tests (IVGTTs), and bioelectrical impedance measurements were performed at 15-month intervals for up to 5 years, or until fasting plasma glucose exceeded 140 mg/dl (7.8 mmol/l). A total of 60 non-diabetic women had a median of four sets of OGTT + IVGTT during a median follow-up of 52 months. Fourteen of the women developed diabetes. None of the baseline characteristics were significantly predictive of a decline in DI. There were significant univariate associations between declining DI and weight gain (specifically fat gain), declining adiponectin and rising C-reactive protein. Multivariate analysis showed that the weight gain was the most significant factor associated with declining DI. The amount of association between weight gain and declining DI was explained 31% by changes in adiponectin and C-reactive protein and 40% by changes in insulin resistance. (Xiang et al., 2010)

      A prospective nested case-control study in a pregnancy cohort measured first-trimester C-reactive protein (CRP) levels in 43 women who subsequently developed GDM and in a random sample of 94 women who remained euglycemic throughout pregnancy. First-trimester CRP levels were significantly increased among women who subsequently developed GDM compared with control subjects (3.1 vs. 2.1 mg/l, P < 0.01). The risk of developing GDM among women in the highest CRP tertile compared with the lowest tertile was 3.2 (95% CI 1.2-8.8). After adjusting for age, race/ethnicity, smoking, parity, blood pressure, and gestational age at CRP sampling, the risk of developing GDM among women in the highest compared with the lowest tertile was 3.6 (95% CI 1.2-11.4). When BMI was included in the model, however, the association between increased CRP and GDM was attenuated (odds ratio for the highest compared with lowest tertile 1.5 [95% CI 0.4-5.5]). In women who develop GDM, there is evidence of increased inflammation during the first trimester. This association is mediated in part by increased BMI. (Wolf et al., 2003)

      A study examined the association between C-reactive protein (CRP) and GDM risk. Women were recruited before 16 weeks gestation and were followed until delivery. Maternal serum CRP was collected at 13 weeks' gestation, on average. Approximately 4.5% of the cohort (38 of 851) developed GDM. Elevated CRP was positively associated with GDM risk (P for trend = 0.007). After adjusting for maternal prepregnancy body mass index (BMI), family history of type 2 diabetes and nulliparity, women with CRP in the highest tertile experienced a 3.5-fold increased risk of GDM [95% CI 1.2, 9.8] as compared with those in the lowest tertile. The association between CRP and GDM was evident when analyses were restricted to lean women (BMI < 25 kg/m(2)). Lean women with CRP > or = 5.3 mg/L experienced a 3.7-fold increased risk of GDM [95% CI 1.6, 8.7] as compared with women with CRP < 5.3 mg/L. Systemic inflammation is associated with an increased risk of GDM, and the association is independent of maternal prepregnancy adiposity. (Qiu et al., 2004)

      SHBG

      A nested case-control study included women who participated in the Kaiser Permanente Northern California Multiphasic Health Check-up examination (1984-1996) and had a subsequent pregnancy (1984-2009). Eligible women were free of recognized diabetes. Case patients were 256 women in whom GDM developed. Two control subjects were selected for each case patient, and were matched for year of blood draw, age at examination, age at pregnancy, and number of intervening pregnancies. Compared with the highest quartile of SHBG concentrations, the odds of GDM increased with decreasing quartile (odds ratio 1.06 [95% CI 0.44-2.52]; 2.33 [1.07-5.09]; 4.06 [1.90-8.65]; P for trend < 0.001), after adjusting for family history of diabetes, pre-pregnancy BMI, race/ethnicity, alcohol use, pre-pregnancy weight changes, and homeostasis model assessment of insulin resistance. Having SHBG levels below the median (<64.5 nmol/L) and a BMI >/=25.0 kg/m2 was associated with fivefold increased odds of GDM compared with normal-weight women with SHBG levels at or above the median (5.34 [3.00-9.49]). Low pre-pregnancy SHBG concentrations were associated with increased risk of GDM and might be useful in identifying women at risk for GDM for early prevention strategies. (Hedderson et al., 2014)

      A nested case-control study included 44 patients with gestational diabetes mellitus and 94 women with negative third-trimester screening for gestational diabetes mellitus. Compared with women without gestational diabetes mellitus, first-trimester sex hormone binding globulin levels were lower among women in whom gestational diabetes mellitus subsequently developed (187 +/- 82 nmol/L vs 233 +/- 92 nmol/L, P <.01). In logistic regression analysis that was adjusted for body mass index, age, race, smoking, blood pressure, serum testosterone and estradiol levels, and gestational age at serum collection, sex hormone binding globulin levels remained independently associated with subsequent gestational diabetes mellitus. For every 50-nmol/L increase in sex hormone binding globulin, the odds of gestational diabetes mellitus fell by 31% (odds ratio, 0.69; 95% CI: 0.48, 0.99). Sex hormone binding globulin offers a potential early marker to target women who are at risk for gestational diabetes mellitus. (Thadhani et al., 2003)

      Comprehensive Thyroid Panel

      There were 61 pregnant diabetic women in study group and 35 pregnant women in control group. About 36% of patients had GDM and 64% pre-gestational DM. Thyroid dysfunction was detected in 18% of study group compared with 8.6% of control group (P = 0.2). There was Thyroid dysfunction in 4.5% of GDM and 25.6% of pre-gestational DM (P = 0.045). There was no statistically significant difference between thyroid dysfunction in GDM group and control group (P=0.99).27% of GDM and 36% of pre-gestational DM and 23% of control group had positive titer of Anti TPO Ab without statistically significant differences among the three

      Enjoying the preview?
      Page 1 of 1